Clinical Trials in Ascoli Piceno, Italy
8 recruiting
Showing 1–11 of 11 trials
Recruiting
Phase 3
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Adult Acute Myeloid Leukemia
Priothera SAS366 enrolled108 locationsNCT05429632
Recruiting
Phase 2
Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.
Multiple Myeloma (MM)
European Myeloma Network B.V.150 enrolled29 locationsNCT07107529
Recruiting
Phase 3
Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
End Stage Renal Disease
Iperboreal Pharma Srl170 enrolled41 locationsNCT03994471
Recruiting
Phase 3
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Follicular Lymphoma ( FL)
Regeneron Pharmaceuticals822 enrolled190 locationsNCT06091254
Recruiting
Not Applicable
Connected Care for Type 2 Diabetes Self-Management
Diabetes Type 2
Marche Region Regional Health Agency388 enrolled13 locationsNCT07149610
Recruiting
Study on Plasmablastic Lymphoma Patients
Plasmablastic Lymphoma
Fondazione Italiana Linfomi - ETS200 enrolled23 locationsNCT06781359
Recruiting
The Predictive Value of Dobutamine Echo-stress in the Clinical Response to CCM Therapy in Advanced HF
Symptomatic Congestive Heart Failure
Quovadis Associazione120 enrolled13 locationsNCT06973902
Recruiting
Not Applicable
Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS
Coronary DiseaseCoronary Artery DiseaseIschemic Heart Disease
Centro per la Lotta Contro l'Infarto - Fondazione Onlus1,420 enrolled34 locationsNCT05027984
Recruiting
Phase 3
Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)
High-risk MDS
Gruppo Italiano Malattie EMatologiche dell'Adulto274 enrolled46 locationsNCT04184505
Recruiting
Phase 3
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Acute Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto414 enrolled48 locationsNCT04168502
Recruiting
Phase 3
Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy
Diffuse Large B Cell LymphomaElderly Patients
Fondazione Italiana Linfomi - ETS430 enrolled49 locationsNCT04442412